10 mg: Rivaroxaban is indicated for the prevention of venous thromboembolism (VTE) in patients undergoing major orthopedic surgery of the lower limbs.
Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent DVT and PE in adults.
15 mg and 20 mg: Rivaroxaban is indicated for prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation.
Rivaroxaban is indicated for the treatment of Deep Vein Thrombosis (DVT) and for the prevention of recurrent DVT and Pulmonary Embolism (PE) following an acute DVT in adults.
Rivaroxaban is indicated for the treatment of Pulmonary Embolism (PE) and for the prevention of recurrent PE and DVT.
Sign Out